Tuesday, 04 March 2025

 

 

LATEST NEWS Droupadi Murmu Inaugurates Visitor’s Conference 2024-25 IAF Capability Enhancement Report Presented to Defence Minister Rajnath Singh National duty of every citizen to contribute to the welfare of soldiers & their families : Rajnath Singh at CSR Conclave Yudh Nashian Virudh: DC urges social, religious, sports organisations to come forward against drug abuse First All India Police Kabaddi Cluster Kicks Off in Jalandhar Randeep Hooda Shares Stunning Wildlife Photos, Advocates Conservation on World Wildlife Day Harjot Singh Bains & Finland Ambassador Launch Teacher Training Program Yudh Nashian Virudh : Big action on illegal property of Drug Smuggler in Bathinda Is Anora Available On OTT? Let’s Explore with 5 Dariya News From Nominees to Winners: The Inside Scoop on the Oscars Academy Awards India and Nepal Sign MoU to Strengthen Cooperation in Water, Sanitation, and Hygiene (WASH) INS Shardul, INS Sujata, and ICGS Veera Arrive in Thailand to Strengthen Maritime Cooperation India and Japan Declare 2025-26 as Year of Science & Technology Exchange Oscar Winning Actress Mikey Madison Net Worth 2025: Unveiling Her Income Sources & Career Highlights Sanjeev Arora Discusses Industrial Concerns with Bhagwant Mann India’s R&D Spending Doubles in a Decade, Driving Innovation in AI, Biotech & Quantum Computing Amit Shah Inaugurates Workshop on Sustainability & Circularity in Dairy Sector Punjab Police Busts Cybercrime Racket: Prime Accused Arrested for Running Fake Mining Department Website Himanshu Jain orders Health Department to promote anti-drug campaign to every village of Distt Rupnagar The LaLiga Showdown: Barcelona Vs Real Madrid Kuldeep Singh Pathania calls on Shiv Pratap Shukla

 

Hybrid immunity best protection against Covid-19 : Researchers

XE variant, Omicron Variant, Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, Health, Research, Study, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Liquid Medical Oxygen, Oximeter

Web Admin

Web Admin

5 Dariya News

Toronto , 22 Jan 2023

People with hybrid immunity are the most protected against severe illness and reinfection, a new study has found. Results from global data show vaccination and a prior Covid-19 infection offer the best defence against severe illness and reinfection, according to a University of Calgary research group.

Hybrid immunity occurs when someone has had at least the full series of vaccines and has a prior infection, in any order. The study published in The Lancet Infectious Diseases will help public policy makers understand the optimal timing of vaccinations.

"The results reinforce the global imperative for vaccination. A common question throughout the pandemic was whether previously infected people should also get vaccinated. 

Our results clearly indicate the need for vaccination, even among people who have had Covid-19," said Dr Niklas Bobrovitz, first author on the study. 

In the study, investigators were able to look at immune protection against Omicron after a prior SARS-CoV-2 infection (the virus that causes Covid-19), vaccination, or hybrid immunity.

"Protection against hospitalization and severe disease remained above 95 per cent for 12 months for individuals with hybrid immunity," said Dr Lorenzo Subissi, WHO-Scientist and senior author on the study.

The systematic review and meta-analysis find that protection against Omicron infection declines substantially by 12 months, regardless of whether you've had an infection, vaccinations, or both.

It means that vaccination is the best way to periodically boost your protection and to keep down levels of infection in the population. While the findings demonstrate that vaccination along with a prior infection carries the most protection, the scientists warn against intentional exposure to the virus.

"You should never try to get Covid-19," said Bobrovitz. "The virus is unpredictable in how it will affect your system. For some, it can be fatal or send you to hospital. Even if you have a mild infection, you risk developing a long Covid."

 

Tags: XE variant , Omicron Variant , Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , Health , Research , Study , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Liquid Medical Oxygen , Oximeter

 

 

related news

 

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2025 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD